About Us

Luye Pharma Group (02186.HK), a member of Luye Life Sciences Group, is an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications.

On The Road

Luye Pharma’s Innovative Formulation LY03010 Meets Endpoints in Pivotal U.S. Study

News

Shanghai, November 21, 2022 - Luye Pharma Group announced today that a pivotal study conducted in the U.S. for the company's in-house developed innovative formulation, Paliperidone Palmitate Extended-release Injectable Suspension ...

November 21,2022

China’s First Denosumab Biosimilar Boyoubei® Approved for Launch by NMPA

Shanghai, November 10, 2022 – Luye Pharma Group today announced that Denosumab Injection (Boyoubei®) developed by its subsidiary Boan Biotech has been approved for launch in China by the National Medical Products Administration ...

November 10,2022

Read More

Investors

Employee Stories

Upholding the philosophy of “Employee Development”,
Luye Pharma regards employees as the most valuable resources of the company